GRK2 and medulloblastoma: Here we reported that attenuation of cisplatin- and etoposide-induced apoptosis was similar in medulloblastoma cells expressing wildtype GRK2, the kinase-dead mutant GRK2-K220R65 or the non-phosphorylated constitutively-kinase-active mutant GRK2-S670A2.